Codiak Biosciences Inc (CDAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CDAK | AMGN | VRTX | BMY | REGN |
| Company | Codiak Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.1100 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 0.1100 | 322.60 | 405.67 | 44.33 | 958.13 |
| Low | 0.0532 | 308.68 | 397.63 | 43.69 | 926.94 |
| Last | 0.0570 | 311.34 | 401.08 | 43.99 | 957.00 |
| Change | -0.0725 | +32.95 | +0.92 | +0.29 | +19.39 |
| % Change | -55.98% | +11.84% | +0.23% | +0.66% | +2.07% |
| Volume | 14,634,700 | 9,611,084 | 1,062,883 | 11,979,505 | 525,886 |
| 20-Day Average Volume | 4,001,600 | 2,645,209 | 1,022,544 | 14,458,160 | 517,509 |
| Previous Close | 0.1295 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3831 | 272.27 | 398.43 | 47.46 | 909.87 |
| 20-Day Raw Stochastic | 0.67% | 81.82% | 63.17% | 7.87% | 98.64% |
| 20-Day Relative Strength | 25.80% | 72.12% | 47.14% | 29.25% | 59.08% |
| Weighted Alpha | -91.75 | +33.79 | +14.36 | -36.67 | +26.69 |
| Today's Opinion | 100% Sell | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 100% Sell | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 72% Sell | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -70.00% since 03/28/23 | +15.32% since 04/26/24 | +0.91% since 04/26/24 | -1.92% since 04/26/24 | +8.36% since 04/26/24 |
| Low | 0.0532 on 04/04/23 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 0.2100 on 03/30/23 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 958.13 on 05/03/24 |
| 1-Month | |||||
| %Chg | -89.75% since 03/03/23 | +13.45% since 04/03/24 | -1.89% since 04/03/24 | -15.70% since 04/03/24 | +0.64% since 04/03/24 |
| Low | 0.0532 on 04/04/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 0.6200 on 03/17/23 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | -88.93% since 01/04/23 | -3.67% since 02/02/24 | -5.56% since 02/02/24 | -9.69% since 02/02/24 | +1.25% since 02/02/24 |
| Low | 0.0532 on 04/04/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 0.9378 on 02/03/23 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -93.16% since 10/04/22 | +15.37% since 11/03/23 | +6.61% since 11/03/23 | -16.72% since 11/03/23 | +17.15% since 11/03/23 |
| Low | 0.0532 on 04/04/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 0.9600 on 11/02/22 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,099 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 36,830 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 22,940,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -37,160,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 28,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -19,278,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 3.71 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.77 on 11/03/22 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/04/23 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |